Quality Ingredients

10 Years Manufacturing Experience

People for Whom Chondroitin is Suitable

Aminoglycan chondroitin is suitable for a wide range of people and is mainly used in cases where joints are prone to wear and tear, mainly for the following groups of people.

1、Middle-aged and Elderly People
Middle-aged and elderly people have degenerated joint cartilage due to age, and long-term wear and tear will lead to stiff and swollen joints. Some middle-aged and elderly people will feel sore joints after a long time of activity, so supplementing with some amylose chondroitin can slow down the degeneration of cartilage and improve arthritis.

2、Sports Crowd
People who like to exercise, especially runners and joint problems and diseases caused by long-term, periodic exercise, as well as joint discomfort caused by incorrect movement and posture during exercise, joint wear and tear is more serious than normal people, supplementation of amylose chondroitin can effectively reduce joint discomfort and promote joint cartilage repair and regeneration.

图

3、Specific Occupational Groups
Physical workers and dancers need to stand and walk for a long time due to the special nature of their profession, and the overuse of joints can easily lead to joint strain and osteoarthritis, so you can prevent joint diseases by daily supplementation of amylose chondroitin.

4、Office Staff
Office population to maintain the same posture for a long time, the neck, shoulder joints under pressure, prone to lumbago and periapical pain and other problems, supplemental aminoglycan chondroitin can effectively do anti-inflammatory analgesia, protect the joint bone stiffness damage.

Most current clinical studies on arthritis have found that taking 1200 mg of chondroitin daily can effectively improve the painful inflammation of arthritis. Chondroitin is not a pain-relieving and anti-inflammatory ingredient. When diagnosed with degenerative arthritis or arthritis caused by overloading of joints, chondroitin must be taken continuously for at least six months until the conditions that cause the joint burden are lifted.


Post time: Mar-11-2023